Headache Journal

2024 Resident Education Program

Start Date: 10/25/2024
End Date: 10/27/2024
Location: In-person Event UCLA Meyer and Renee Luskin Conference Center Los Angeles, CA

Add to Google Calendar

Sponsorship

The American Headache Society gratefully acknowledges the support of the 2024 Resident Education Program from our industry supporters:

PLATINUM

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

GOLD

Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit lilly.com and lilly.com/newsroom or follow us on Facebook, Instagram, and LinkedIn.

The American Headache Society gratefully acknowledges the educational grant support of the 2024 Resident Education Program from our industry supporters:

AbbVie Inc.
Eli Lilly and Company
Lundbeck LLC